Evidence map›Paper›PMID 40298430›Full record

ArticleCancer research2025

The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse Models.

Ling Cai, Fangjiang Wu, Qinbo Zhou, Ying Gao, Bo Yao, Ralph J DeBerardinis, George K Acquaah-Mensah, Vassilis Aidinis, Jennifer E Beane, Shyam Biswal and 38 more

Abstract readComparative Study
In one paragraph

Article in Cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Ling CaiQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-8592-5269
Fangjiang WuQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0001-8812-8655
Qinbo ZhouQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-7967-2138
Ying GaoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.ORCID 0009-0006-5110-1268
Bo YaoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.ORCID 0009-0002-2225-9956
Ralph J DeBerardinisChildren's Research Institute, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-2705-7432
George K Acquaah-MensahMassachusetts College of Pharmacy & Health Sciences, Worcester, Massachusetts.ORCID 0000-0003-3984-8327
Vassilis AidinisInstitute of Fundamental Biological Research, Biomedical Sciences Research Center Alexander Fleming, Athens, Greece.ORCID 0000-0001-9531-7729
Jennifer E BeaneSection of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-6699-2132
Shyam BiswalDepartment of Environmental Health and Engineering, Johns Hopkins University School of Public Health, Baltimore, Maryland.ORCID 0009-0000-5794-3403
Ting ChenNYU School of Medicine, New York, New York.ORCID 0000-0003-1725-7956
Carla P Concepcion-CrisolColumbia University, New York, New York.ORCID 0000-0003-0529-7360
Barbara M GrünerDepartment of Medical Oncology, West German Cancer Center, University Hospital Essen Essen, Germany.ORCID 0000-0003-0974-4826
Deshui JiaInstitute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-2784-126X
Robert A JonesDepartment of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada.ORCID 0000-0001-7665-9301
Jonathan M KurieDepartment of Thoracic-Head & Neck Med Onc, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-1472-8719
Min Gyu LeeDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0003-0859-0642
Per LindahlSahlgrenska Center for Cancer Research Institute of Biomedicine | Department of Medical Biochemistry and Cell Biology, University of Gothenburg Gothenburg, Sweden.ORCID 0000-0001-9539-3959
Yonathan LissanuDepartment of Thoracic & Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0003-1024-5303
Corina LorzBiomedical Innovation Unit. Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.ORCID 0000-0001-8214-9076
David MacPhersonFred Hutchinson Cancer Center, Seattle, Washington.ORCID 0000-0003-3729-907X
Rosanna MartinelliDepartment of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Baronissi, Italy.ORCID 0000-0002-6524-6752
Pawel K MazurDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-5820-8344
Sarah A MazzilliSection of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-9187-2722
Shinji MiiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0001-8266-3235
Herwig P MollMedical University of Vienna, Center for Physiology and Pharmacology, Vienna, Austria.ORCID 0000-0001-6438-9068
Roger A MooreheadDepartment of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Canada.ORCID 0000-0001-9539-6295
Edward E MorriseyPenn-CHOP Lung Biology Institute, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0001-5785-1939
Sheng Rong NgInstitute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.ORCID 0000-0003-1655-2443
Matthew G OserDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-2047-0969
Arun R PandiriCellular and Molecular Pathology Branch, Division of National Toxicology Program (DNTP), National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, North Carolina.ORCID 0000-0003-0963-9073
Charles A PowellIcahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0003-3509-891X
Giorgio RamadoriDepartment of Cell Physiology and Metabolism, University of Geneva; Geneva, Switzerland.ORCID 0000-0003-0194-3257
Mirentxu SantosBiomedical Innovation Unit. Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.ORCID 0009-0009-9451-2624
Eric L SnyderDepartment of Pathology and Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.ORCID 0000-0003-3591-3195
Rocio SotilloMolecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-0855-7917
Kang-Yi SuDepartment of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.ORCID 0000-0002-6538-9526
Tetsuro TakiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0001-8654-6896
Kekoa TaparraDepartment of Radiation Oncology, Stanford Health Care, Stanford, California.ORCID 0000-0001-8493-3868
Phuoc T TranDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland.ORCID 0000-0002-0147-0376
Yifeng XiaSalk Institute for Biological Studies, San Diego, California.ORCID 0000-0001-9709-7395
J Edward van VeenDepartment of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, California.ORCID 0000-0003-1798-3210
Monte M WinslowDepartment of Genetics, Stanford University School of Medicine, Stanford, California.ORCID 0000-0002-5730-9573
Guanghua XiaoQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0001-9387-9883
Charles M RudinMemorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0001-5204-3465
Trudy G OliverDepartment of Pharmacology & Cancer Biology, Duke University, Durham, North Carolina.ORCID 0000-0003-2082-2397
Yang XieQuantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0001-9456-1762
John D MinnaSimmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas.ORCID 0000-0002-7776-0767

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4M
Project 4: Risk stratification for pulmonary nodules detected by CT imaging using plasma and imaging biomarkersP50CA228944 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI A McGarry Houghton · 2019 to 2026
$19.6M
Coordinating center for the NCI small cell lung cancer research consortiumU24CA213274 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Lauren Averett Byers, JOHN D. MINNA · 2017 to 2026
$12.9M
Metabolic Regulators of Tumor Growth and ProgressionR35CA220449 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI RALPH J DEBERARDINIS · 2017 to 2026
$9.4M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeff G McDonald · 2022 to 2026
$7.4M
Novel therapeutic development for small cell lung cancerR35CA263816 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Charles M. Rudin · 2021 to 2026
$6.3M
Deep Learning Image Analysis Algorithms to Improve Oral Cancer Risk Assessment for Oral Potentially Malignant DisordersR01DE030656 · NIDCR · YALE UNIVERSITY · PI PICKERING, CURTIS, XIAO, GUANGHUA · 2021 to 2025
$3.4M
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancerR37CA251629 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LISSANU, YONATHAN · 2020 to 2025
$3.3M
Transcriptional Regulation of Lung Cancer IdentityR01CA212415 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Eric Lee Snyder · 2017 to 2026
$3.2M
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the LungR01CA240317 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI MAEDA, YUTAKA, SNYDER, ERIC LEE · 2020 to 2024
$3.1M
Finding the optimal balance of immunotherapy efficacy and toxicity.U01AI156189 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI GERBER, DAVID ERIC, WAKELAND, EDWARD K. · 2020 to 2024
$3.1M
American Cancer Society (ACS) IRG-21-142-16Deutsche Forschungsgemeinschaft (DFG) GR4575/1-2Deutsche Forschungsgemeinschaft (DFG) SFB1430Howard Hughes Medical Institute (HHMI)Instituto de Salud Carlos III (ISCIII) PI21/00764National Cancer Institute (NCI) P50CA070907National Cancer Institute (NCI) P50CA228944National Cancer Institute (NCI) R01CA212415National Cancer Institute (NCI) R01CA240317National Cancer Institute (NCI) R01CA244841National Cancer Institute (NCI) R01CA271540National Cancer Institute (NCI) R01CA272945National Cancer Institute (NCI) R01CA285336National Cancer Institute (NCI) R35CA220449National Cancer Institute (NCI) R35CA263816National Cancer Institute (NCI) R37CA251629National Cancer Institute (NCI) U01CA213338National Cancer Institute (NCI) U01CA249245National Cancer Institute (NCI) U24CA213274National Institute of Allergy and Infectious Diseases (NIAID) U01AI156189National Institute of Dental and Craniofacial Research (NIDR) R01DE030656National Institute of General Medical Sciences (NIGMS) R01GM140012National Institute of General Medical Sciences (NIGMS) R01GM141519National Institute of General Medical Sciences (NIGMS) R35GM136375NCI NIH HHS P30 CA008748NCI NIH HHS P50 CA070907NCI NIH HHS P50 CA228944NCI NIH HHS R01 CA212415NCI NIH HHS R01 CA240317NCI NIH HHS R01 CA244841NCI NIH HHS R01 CA271540NCI NIH HHS R01 CA272945NCI NIH HHS R01 CA285336NCI NIH HHS R35 CA220449NCI NIH HHS R35 CA263816NCI NIH HHS R37 CA251629NCI NIH HHS U01 CA213338NCI NIH HHS U01 CA249245NCI NIH HHS U24 CA213274NIAID NIH HHS U01 AI156189NIDCR NIH HHS R01 DE030656NIDDK NIH HHS P30 DK127984NIGMS NIH HHS R01 GM140012NIGMS NIH HHS R01 GM141519NIGMS NIH HHS R35 GM136375
6 · The paper itself

Abstract

Lung cancer, the leading cause of cancer mortality, exhibits diverse histologic subtypes and genetic complexities. Numerous preclinical mouse models have been developed to study lung cancer, but data from these models are disparate, siloed, and difficult to compare in a centralized fashion. In this study, we established the Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB), an extensive repository of 1,354 samples from 77 transcriptomic datasets covering 974 samples from genetically engineered mouse models (GEMM), 368 samples from carcinogen-induced models, and 12 samples from a spontaneous model. Meticulous curation and collaboration with data depositors produced a robust and comprehensive database, enhancing the fidelity of the genetic landscape it depicts. The LCAMGDB aligned 859 tumors from GEMMs with human lung cancer mutations, enabling comparative analysis and revealing a pressing need to broaden the diversity of genetic aberrations modeled in the GEMMs. To accompany this resource, a web application was developed that offers researchers intuitive tools for in-depth gene expression analysis. With standardized reprocessing of gene expression data, the LCAMGDB serves as a powerful platform for cross-study comparison and lays the groundwork for future research, aiming to bridge the gap between mouse models and human lung cancer for improved translational relevance. Significance: The Lung Cancer Autochthonous Model Gene Expression Database (LCAMGDB) provides a comprehensive and accessible resource for the research community to investigate lung cancer biology in mouse models.

Indexed as

Databases, GeneticLung NeoplasmsTranscriptomeAnimalsDisease Models, AnimalGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMice

Identifiers

PMID40298430
PMCPMC12081188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.